---
title: "Revolution Medicines CEO Mark A. Goldsmith reports disposal of common shares worth $16.87 million"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/297030865.md"
description: "Revolution Medicines CEO Mark A. Goldsmith exercised options for 80,000 shares at $4.73 and sold them on Aug 21, 2026, at prices between $207.23 and $212.08, totaling approximately $16.87 million. His direct holdings dropped to 267,330 shares. Two revocable trusts also reported small sales, leaving 61,424 shares each, while a separate trust holds 594,060 shares indirectly."
datetime: "2026-08-26T10:52:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/297030865.md)
  - [en](https://longbridge.com/en/news/297030865.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/297030865.md)
generator: "portal-rs"
---

# Revolution Medicines CEO Mark A. Goldsmith reports disposal of common shares worth $16.87 million

-   Revolution Medicines CEO Mark A. Goldsmith exercised stock options for 80,000 shares at USD 4.73 on Aug. 21, 2026. \* He sold 80,000 shares the same day in open-market transactions at weighted-average prices near USD 207.23 to USD 212.08. \* Directly held common stock fell to 267,330 shares following the transactions. \* Two revocable trusts reported small same-day sales, leaving 61,424 shares in each trust. \* A separate revocable living trust reported 594,060 shares held indirectly. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Revolution Medicines Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001610717-26-000387), on August 25, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [RVMD.US](https://longbridge.com/en/quote/RVMD.US.md)
- [RVMDW.US](https://longbridge.com/en/quote/RVMDW.US.md)

## Related News & Research

- [Did First RASONQUE (daraxonrasib) Approval and NEJM Data Just Shift Revolution Medicines' (RVMD) Investment Narrative?](https://longbridge.com/en/news/298213245.md)
- [Revolution Medicines Got Its Breakthrough—What Moves It Next?](https://longbridge.com/en/news/298062833.md)
- [Axon CEO Patrick W. Smith sells 10,000 shares worth $5.08 million](https://longbridge.com/en/news/298643458.md)
- [Better Home & Finance says Better Mortgage President Chad Smith exits under separation deal](https://longbridge.com/en/news/298362880.md)
- [Matrix Service CFO Andrew J. Smith files initial beneficial ownership statement](https://longbridge.com/en/news/298961741.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**